Therapeutic Inhibition of Platelet Function in Stroke

Publisher： Karger

E-ISSN： 1421-9786|8|5|8-18

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.8, Iss.5, 2004-11, pp. : 8-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The PFA-100® cannot detect blood group-dependent inhibition of platelet function by eptifibatide or abciximab at therapeutic plasma concentrations

By Feuring M.   Ruf A.   Schultz A.   Wehling M.  

Platelets, Vol. 21, Iss. 3, 2010-08 ,pp. : 176-182

Informa Healthcare

Access to resources Recommend Favorite

Optimal Platelet Inhibition following Acute Ischemic Stroke

By  

Cerebrovascular Diseases, Vol. 33, Iss. 6, 2012-06 ,pp. : 579-579

Karger

Access to resources Recommend Favorite

Impact of ABO blood groups on tirofiban mediated inhibition of platelet function

By Feuring M.   Harenberg J.   Peiter A.   Ganschow A.   Ruf A.   Losel R.   Wehling M.   Schultz A.  

Platelets, Vol. 16, Iss. 7, 2005-11 ,pp. : 430-434

Informa Healthcare

Access to resources Recommend Favorite

Incomplete inhibition of platelet function as assessed by the platelet function analyzer (PFA-100) identifies a subset of cardiovascular patients with high residual platelet response while on aspirin

By Crescente M.   Mezzasoma A. M.   Del Pinto M.   Palmerini F.   Di Castelnuovo A.   Cerletti C.   De Gaetano G.   Gresele P.  

Platelets, Vol. 22, Iss. 3, 2011-05 ,pp. : 179-187

Informa Healthcare

Access to resources Recommend Favorite

Activated coagulation/fibrinolysis system and platelet function in acute thrombotic stroke patients with increased C-reactive protein levels

By Tohgi H.   Konno S.   Takahashi S.   Koizumi D.   Kondo R.   Takahashi H.  

Thrombosis Research, Vol. 100, Iss. 5, 2000-12 ,pp. : 373-379

Elsevier

Access to resources Recommend Favorite